June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Intraoperative OCT-assisted DSAEK Surgery in the PIONEER Study
Author Affiliations & Notes
  • Brian Cost
    Cleveland Clinic Foundation, Cleveland, OH
  • Katie Marie Hallahan
    Cleveland Clinic Foundation, Cleveland, OH
  • William J Dupps
    Cleveland Clinic Foundation, Cleveland, OH
  • Jeff Goshe
    Cleveland Clinic Foundation, Cleveland, OH
  • Sunil K Srivastava
    Cleveland Clinic Foundation, Cleveland, OH
  • Justis P Ehlers
    Cleveland Clinic Foundation, Cleveland, OH
  • Footnotes
    Commercial Relationships Brian Cost, None; Katie Hallahan, None; William Dupps, Carl Zeiss Meditec (F); Jeff Goshe, None; Sunil Srivastava, Allergan (F), Bausch and Lomb (C), Bausch and Lomb (F), Bioptigen (P), Synergetics (P); Justis Ehlers, Alcon (C), Alcon (C), Alcon (C), Bioptigen (C), Bioptigen (P), Genentech (F), Leica (C), Synergetics (P), Synergetics (P), Thrombogenics (C), Thrombogenics (F), Zeiss (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1575. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brian Cost, Katie Marie Hallahan, William J Dupps, Jeff Goshe, Sunil K Srivastava, Justis P Ehlers; Intraoperative OCT-assisted DSAEK Surgery in the PIONEER Study. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1575.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate the role of intraoperative optical coherence tomography (iOCT) during Descemet stripping automated endothelial keratoplasty (DSAEK) in the PIONEER (Prospective Intraoperative and Perioperative Ophthalmic ImagiNg with Optical CohEncE TomogRaphy) study.

 
Methods
 

The PIONEER study is a multi-surgeon prospective IRB-approved study that assessed iOCT feasibility and utility in ophthalmic surgery. This analysis includes eyes undergoing DSAEK from PIONEER. Clinical characteristics and outcomes were assessed up to 6 months post-operatively. iOCT images were captured at multiple time points during surgery. A novel automated algorithm evaluated intraoperative dynamics of interface fluid following surgical manipulations.

 
Results
 

Two hundred-one eyes of 174 patients (129 female, 73 male) with mean age of 71 (range: 21-95) were included. The most common indications were Fuchs Endothelial Dystrophy (65%), Bullous Keratopathy (20%) and previously failed DSAEK (8%). The most common previous surgeries on the study eye were vitrectomy (10%), previous DSAEK (9%) and aqueous tube shunts (7%). Mean preoperative visual acuity was 20/132, which improved to 20/46 following surgery (p < 0.0001). There were 16 (8%) graft dislocations, of which 11 eyes had at least one ocular comorbidity (p = 0.0007). Significant interface fluid was often present following graft placement. Fluid volume changed notably during intraoperative manipulations (Figure 1) with a mean decrease of 0.449 µL (range -0.175-4.715 µL). Postoperative interface haze was found in 24% of patients at POM#1, 18% at POM#3, and 11% at POM#6 and was associated with postoperative residual interface fluid. Surgeon feedback indicated that iOCT informed surgical decision-making and altered understanding of graft apposition in 118 out of 201 cases (59%).

 
Conclusions
 

iOCT-assisted DSAEK surgery provides new information about the amount and location of interface fluid following graft placement. This may facilitate surgical maneuvers to minimize residual interface fluid prior to completing surgery which may reduce the risk of postoperative interface haze and speed visual recovery. Ocular comorbidities appear to be an important factor in DSAEK graft dislocation.  

 
(A) Post-graft insertion with interface fluid present. (B) Post-graft insertion with segmented interface fluid. (C) Post-manipulation resulting in reduced interface fluid. (D) Post-manipulation with segmented interface fluid.
 
(A) Post-graft insertion with interface fluid present. (B) Post-graft insertion with segmented interface fluid. (C) Post-manipulation resulting in reduced interface fluid. (D) Post-manipulation with segmented interface fluid.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×